Want to see FR:ALGAE full AI Analyst Report?
ALGAE Stock Chart & Stats
€0.46
<€0.01(1.27%)
At close: 4:00 PM EDT
€0.46
<€0.01(1.27%)
Day’s Range― - ―
52-Week Range€0.40 - €0.64
Previous CloseN/A
Volume36.82K
Average Volume (3M)79.76K
Market Cap
€49.48M
Enterprise Value€44.58M
Total Cash (Recent Filing)€10.79M
Total Debt (Recent Filing)€3.93M
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Apr 16, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding119,968,735
10 Day Avg. Volume111,440
30 Day Avg. Volume79,762
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.78
Price to Sales (P/S)3.34
P/FCF Ratio-5.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.08
Revenue Forecast (FY)€19.35M
Bulls Say, Bears Say
Bulls Say
Revenue ExpansionStrong revenue expansion indicates improving commercial traction for Fermentalg’s microalgae-derived products and know-how. If maintained, the larger revenue base can provide operating leverage, support customer development, and create a foundation for eventually covering the company’s fixed cost structure.
Improving Gross MarginThe move to a positive gross margin signals better unit economics and suggests that product pricing, production economics, or mix have improved. Sustaining this progress would make incremental revenue more valuable and could support a longer-term path toward profitability as scale develops.
Manageable LeverageLower leverage reduces balance-sheet pressure and leaves the company less exposed to debt servicing demands than in prior years. This provides greater financial flexibility while Fermentalg develops its commercial platform, although the benefit depends on controlling ongoing losses and cash consumption.
Bears Say
Persistent UnprofitabilityPersistent, deeply negative margins show that Fermentalg has not yet scaled its business sufficiently to cover its cost base. Continued losses can constrain reinvestment, weaken financial resilience, and make future growth dependent on achieving substantial operating improvement rather than revenue growth alone.
Worsening Cash BurnMaterial and worsening cash outflows indicate that the business is not yet self-funding its operations and development activities. Ongoing negative free cash flow increases funding needs and could limit strategic flexibility until commercial growth translates into more stable cash generation.
Eroding Equity BaseDeclining equity alongside a sharply negative return on equity reflects the cumulative effect of ongoing losses on shareholder capital. Unless profitability improves, further erosion could reduce balance-sheet resilience and make it harder to finance expansion without additional capital.
ALGAE FAQ
What was Fermentalg SA’s price range in the past 12 months?
Fermentalg SA lowest stock price was €0.40 and its highest was €0.64 in the past 12 months.
What is Fermentalg SA’s market cap?
Fermentalg SA’s market cap is €49.48M.
When is Fermentalg SA’s upcoming earnings report date?
Fermentalg SA’s upcoming earnings report date is Apr 16, 2027 which is in 186 days.
How were Fermentalg SA’s earnings last quarter?
Fermentalg SA released its earnings results on Oct 06, 2026. The company reported -€0.04 earnings per share for the quarter.
Is Fermentalg SA overvalued?
According to Wall Street analysts Fermentalg SA’s price is currently Overvalued.
Does Fermentalg SA pay dividends?
Fermentalg SA does not currently pay dividends.
What is Fermentalg SA’s EPS estimate?
Fermentalg SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fermentalg SA have?
Fermentalg SA has 119,968,735 shares outstanding.
What happened to Fermentalg SA’s price movement after its last earnings report?
Fermentalg SA reported an EPS of -€0.04 in its last earnings report. Following the earnings report the stock price went up 0.459%.
Which hedge fund is a major shareholder of Fermentalg SA?
Currently, no hedge funds are holding shares in FR:ALGAE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fermentalg SA
Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve various industries, including food, health, nutritional supplements, and environmental protection. Their product portfolio features DHA ORIGINS, a plant-derived DHA oil; KALVEA PLUS, a high-protein algal concentrate tailored for aquaculture feed; Everzure, a naturally occurring, acid-stable blue colorant; BLUE ORIGINS AOX, known for its antioxidant and anti-inflammatory benefits; BLUE ORIGIN, another natural coloring agent; and advanced clean air solutions designed for industrial CO2 capture.